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A GENOME-WIDE ASSOCIATION STUDY IDENTIFIES A
LOCUS ON CHROMOSOME 7Q22 TO INFLUENCE
SUSCEPTIBILITY FOR OSTEOARTHRITIS
H.J. Kerkhof1, R.J. Lories2, I. Meulenbelt3, I. Jonsdottir4,
A.M. Valdes5, A. Carr6, M. Doherty7, D.T. Felson8, A. Gonzalez9,
D.J. Hart5, A. Hofman1, J.P. Ioannidis10, N.E. Lane11,
J. Loughlin12, F.P. Luyten2, M.C. Nevitt11, K. Stefansson4,
H.A. Pols1, F. Rivadeneira1, E.P. Slagboom3, U. Styrkarsdottir4,
A. Tsezou13, T.D. Spector5, A.G. Uitterlinden1, J.B. Van Meurs1
1Erasmus Med. Ctr., Rotterdam, Netherlands; 2Katholieke Univ.it
Leuven, Leuven, Belgium; 3Leiden Univ. Med. Ctr., Leiden,
Netherlands; 4deCODE Genetics, Reykjavik, Iceland; 5King’s Coll.
London, London, United Kingdom; 6Nufﬁeld Orthopaedic Ctr.,
Oxford, United Kingdom; 7Univ. of Nottingham, Nottingham,
United Kingdom; 8Boston Univ. Sch. of Med., Boston, MA; 9Hosp.
Clinico Univ.rio Santiago, Santiago de Compostela, Spain; 10Univ.
of Ioannina-Sch. of Med., Ioannina, Greece; 11Univ. of California,
Sacramento, CA; 12Newcastle Univ., Newcastle, United Kingdom;
13Univ. of Thessaly, Larissa, Greece
Purpose: To identify novel genes involved in osteoarthritis (OA)
we performed a Genome-Wide Association Study (GWAS) in
Caucasians.
Methods: In total, 500,510 Single Nucleotide Polymorphisms
(SNPs) were tested for association with osteoarthritis in 1341
OA cases and 3496 Dutch Caucasian Controls. SNPs nominally
associated with at least two OA-phenotypes were analyses in 11
replication studies. In the meta-analysis, 14,938 OA cases and
approximately 39,000 controls were analyzed using the program
Comprehensive Meta-Analysis. A p-value <1×10-7 was consid-
ered genome-wide signiﬁcant (0.05/500,510).
Results: The C-allele of rs3815148 on chromosome 7q22 (MAF
23%, 172 kb upstream of the GPR22 gene) was consistently
associated with a 1.14-fold increased risk (95%CI: 1.09-1.19) for
knee/hand OA (p=8×10-8), and also with an 18% increased risk for
OA progression (p=0.03). This SNP is in almost complete linkage
disequilibrium with rs3757713 (located 68 kb upstream of GPR22)
which is associated with GPR22 expression levels in lymphoblast
cell lines (p=4×10-12). In addition, immunohistochemistry showed
absence of GPR22-protein in normal murine joint tissues, but
detectable levels in arthritic disease in both the articular cartilage
and osteophytes.
Conclusions: Our ﬁndings reveal a novel common variant to
inﬂuence susceptibility for osteoarthritis.
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CYTOKINE-INDUCED CHANGES IN GENE EXPRESSION IN
SHORT-TERM CULTURES DO NOT FULLY MIMIC
ABERRANT EXPRESSION IN OSTEOARTHRITIS:
ADVANTAGES OF LONG-TERM CULTURES
K. Hashimoto1, M.B. Goldring2, H.I. Roach1
1Univ. of Southampton, Southampton, United Kingdom; 2Weill
Cornell Med. Coll., New York, NY
Purpose: Cartilage destruction in osteoarthritis (OA) is due, in
part, to cytokine-induced expression of proteases. In vivo, this
aberrant expression is maintained even in the absence of cy-
tokines and is transmitted to daughter cells, suggesting that epi-
genetic changes result in activating previously silenced genes.
Current in vitro models used for studying transcriptional regulation
consist of treating chondrocytes (primary or the cell line C28/I2)
with cytokines (IL-1β, TNF-α) and investigating gene expression
after a few hours. Many studies have shown that the cytokines
up-regulate catabolic and down-regulate anabolic genes in vitro,
but to what extent does this mimic the situation in OA? We
asked i) whether aberrant expression in vitro was maintained af-
ter cytokine withdrawal; ii) whether it was possible to reproduce
epigenetic changes in vitro and iii) to what extent the cytokine-
induced changes in vitro correlated with in vivo expression by OA
chondrocytes.
Methods: C28/I2 cells were treated with IL-1β and harvested af-
ter 1, 4, 8, 24 and 72 h. Non-OA chondrocytes, obtained after
hemi-arthroplasty, were passaged (P1), then treated once with
IL-1β and harvested after 24 and 72 h. P1 chondrocytes were
also cytokine-treated twice a week for 2-3 weeks, then pas-
saged again and cultured without cytokines for another 2 - 3
weeks. Expression levels of catabolic (IL-1β, TNF-α, MMP-3, -13)
and anabolic (COL2A1, DNMT1) genes were quantiﬁed by qRT-
PCR. DNA methylation was quantiﬁed at a key CpG site of IL-1β
promoter (Epigenetics, 2007; 2: 86-95). mRNA expression was
compared between superﬁcial-zone OA chondrocytes and aged
non-OA chondrocytes.
Results: In C28/I2 cells, induction of catabolic genes by IL-1β
rapidly peaked at 1 - 8 h, depending on the gene investigated, then
declined again. In primary chondrocytes, expression of catabolic
genes increased considerably 24 h after IL-1β treatment, but
decreased after cytokine withdrawal. COL2A1 expression was vir-
tually abolished by IL-1β and not regained after 72 h. The % DNA
methylation did not change during 72 h. Repeated treatment with
IL-1β in long-term culture increased expression of IL-1β and the
MMPs more markedly than single treatment and induced loss of
DNA methylation. Expression and DNA de-methylation was main-
tained after cytokine withdrawal and passaging. While induction of
catabolic genes was also found in superﬁcial-zone OA chondro-
cytes, the repression of anabolic genes was not. Compared with
non-OA ‘old’ chondrocytes, which expressed very low levels of
COL2A1, BMP-7 or IL1R antagonist, these genes were actually
activated in OA chondrocytes.
Conclusions: The widely used short-term cytokine-treated chon-
drocyte cultures do not fully model the in vivo situation for two
reasons: i) Repression of anabolic genes by IL-1β, which is fre-
quently observed in vitro, does not occur in OA, where activation
is observed. ii) Induction of catabolic genes is not maintained in
short-term cultures after cytokine withdrawal and does not corre-
late with DNA de-methylation, whereas in OA it does. However,
long-term treatment can mimic the loss of DNA methylation and
maintain aberrant gene expression of catabolic genes even af-
ter cytokine withdrawal. This model will facilitate studies on the
mechanisms of DNA de-methylation, which might ultimately lead
to novel therapeutic approaches for the treatment of OA.
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POLYMORPHISM IN THE RUNX1 GENE ARE ASSOCIATED
WITH OSTEOARTHRITIS OF THE HIP BUT NOT OF THE
KNEE IN THE UK
F. Zhang1, M. Doherty2, S. Doherty2, F. O’Neil1, T.D. Spector1,
A.M. Valdes1
1King’s Coll. London, London, United Kingdom; 2Academic
Rheumatology, Univ Nottingham, Nottingham, United Kingdom
Purpose: The Runx (runt-related) family of transcription factors
are important regulators of cell fate decisions in early embryonic
development, and in differentiation of tissues. In murine embryonic
development RUNX1 is expressed in pre-chondrocytic conden-
sations, in the perichondrium and periosteum, and in immature
proliferating chondrocytes. Functional data from analysis of limb
bud cell condensations in vitro suggests that RUNX1 mediates the
onset of mesenchymal cell commitment towards chondrogenesis.
Osteoarthritis and Cartilage Vol. 17, Supplement 1 S197
In blood cells RUNX1 directly stimulates G1 to S cell-cycle pro-
gression and regulates speciﬁc genes and cytokine receptors. In
addition, genetic variation in the RUNX1 gene has been implicated
in susceptibility to rheumatoid arthritis in Japanese populations.
We hypothesized that variation in the RUNX1 gene could be
involved in genetic susceptibility to osteoarthritis.
Methods: 1983 knee OA cases (1232 total knee replacement pa-
tients and 751 with radiographic disease only), 1283 hip OA cases
(1119 total hip replacement patients and 149 with radiographic
disease only) and 2317 controls from the UK were genotyped
for three tagging single nucleotide polymorphisms (SNPs) in the
RUNX1 gene and genetic association was tested.
Results: Differences in allele frequencies did not achieve sta-
tistical signiﬁcance between hip OA and controls (p<0.065) nor
between knee OA and controls (p< 0.370). Nevertheless, we found
that the rare homozygotes at both rs2834656 and rs2834662 were
signiﬁcantly associated with lower risk of hip OA OR=0.63 (95% CI
0.46-0.88) p<0.006 and OR=0.70 (95% CI 0.51-0.94) p<0.019 re-
spectively. No such association was seen with knee OA (OR=0.88,
95% CI 0.67- 1.15 and p=0.358)
Conclusions:Our data indicate that polymorphisms in the RUNX1
gene may be involved in genetic susceptibility of hip OA but not
knee OA.This work was supported by the Arthritis and Research
Campaign and by the European Union FP7 large collaborative
project grant 200800 TREAT-OA
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DIO2 METHYLATION IN ARTICULAR CARTILAGE AND
WHOLE BLOOD
S.D. Bos1, B. Duijnisveld1, E. Tobi1, R.G. Nelissen1,
B.T. Heijmans1, P. Slagboom1,2, I. Meulenbelt1
1LUMC, Leiden, Netherlands; 2Netherlands Consortium for Hlth.y
Aging, Leiden, Netherlands
Purpose: Gene activity can be regulated or silenced by epi-
genetic control mechanisms, for example methylation. An EN-
CODE dataset of genome wide transcriptional repressor CCCTC-
binding factor (CTCF) binding shows a CTCF binding peak in the
proximity of rs225014, an OA susceptibility SNP within the DIO2
gene. In this study we set off to explore differences in methylation
status of DIO2 between blood and cartilage DNA as well as in
healthy and OA cartilage.
Methods: We collected cartilage material from subjects under-
going total joint arthroplasty and whole blood from OA patients.
Cartilage was snap frozen in liquid nitrogen and stored at -80°C.
Cartilage was ground up in a Retsch MM200 sample disintegrator
and RNA and DNA were extracted using Qiagen columns. Blood
DNA was collected by use of a Qiagen column. DNA was bisulﬁte
treated using the Zymo Research EZ DNA methylation bisulﬁte
kit and 13 DIO2 CpG sites were PCR ampliﬁed and quantitatively
assessed for DNA methylation using a mass spectrometry based
method (Epityper, Sequenom).
Results: The DNA methylation levels in cartilage (N=3) and blood
(N=7) could be analyzed for 12 out of 13 DIO2 CpG dinucleotides.
Overall, our preliminary data show that blood DNA performed
better upon bisulﬁte treatment as compared to cartilage DNA,
giving more robust data for blood. However, overall the methylation
status of the DIO2 in cartilage appeared higher as compared to
blood. For blood the average DIO2 methylation was 0.67, with
methylation status per CpG dinucleotide ranging from an average
of 0.1 to 0.96 (mean standard deviation 0.23 ranging from 0.04 to
0.17).
Conclusions: These preliminary data indicate that CpG methy-
lation within the DIO2 gene varies between individuals and that
we can consistently measure this variation. The overall hyper-
methylation of DIO2 in healthy cartilage as compared to blood
might be indicative of epigenetic control of the DIO2 within dif-
ferent tissues. This should be substantiated through the ongoing
collection of DNA from both healthy and OA affected cartilage,
which may also provide insights in possible differential methylation
of DIO2 in OA. Unraveling epigenetic regulation at developmental
genes within cartilage may elucidate additional mechanisms of the
complex etiology of OA.
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ASSOCIATION OF LEPTIN GENE (LEP) WITH BODY MASS
INDEX (BMI) IN HAN CHINESE
J. Qin
Drum Tower Hosp. Afﬁliated to, NanJing, China
Purpose: Although the number of candidate genes has increased
and several polymorphisms have been studied in human popu-
lations, knowledge about genetic factors underlying the suscep-
tibility to obesity remains incomplete. This study assessed the
contribution of leptin gene polymorphism to BMI in Chinese Han
population.
Methods: 3 tag SNPs of LEP were selected by haploviewer
software from Hapmap database. They cover all the SNPs of
LEP whose heterozygosis rate are over 10%. We genotyped the
selected SNPs in 615 individuals ≥40 years old live in and around
Nanjing, China, compared allelic and genotypic frequencies and
haplotype distribution between normal range (BMI = 18.50-24.99)
and overweight (BMI ≥ 25.00) groups.
Results: Associations were observed in haplotype CAT (P=0.009)
and AGC (P=0.005) between the two groups, with the sequence
of loci chosen for hap-analysis is rs11761556, rs12706832,
rs2071045. No association between the genotypes and allele
frequences was observed between the two groups.
Conclusions: These ﬁndings suggest there is an association be-
tween LEP and BMI and it’s a ﬁrst report examined the relationship
between LEP polymorphisms and BMI in Han Chinese.
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LARGE-SCALE ASSOCIATION STUDY OF SUSCEPTIBILITY
GENES FOR LUMBAR DISC HERNIATION
S. Ikegawa
CGM, RIKEN, Tokyo, Japan
Purpose: Lumbar disc herniation (LDH) is a common disease,
a predominant cause of low back pain and unilateral leg pain.
Although many risk factors have been reported for LDH, its etiol-
ogy and pathogenesis are for the most part unknown. The strong
familial predisposition for LDH and lumbar disc degeneration has
been established through a number of family and twin studies.
Recently, several susceptibility genes have been reported to asso-
ciate with LDH and related conditions. Most encode extracellular
matrix (ECM) proteins in the intervertebral disc, suggesting the
importance of ECM metabolism in LDH. The aim of the study is
to examine susceptibility genes for LDH through a candidate gene
approach for the cartilage genes.
Methods: Subjects.
Case-control association analyses were performed for LDH can-
didate genes by a two-step screening. We recruited a total of
nearly 1,000 cases and 1,000 controls for the ﬁrst screen and
the replication study. Affected individuals with LDH were recruited
from 19 collaborating hospitals. The diagnosis of LDH required the
following three criteria: 1) diagnosis of LDH by MRI; 2) treatment
and monitoring for >1 year by orthopedic surgeons; and 3) a
history of unilateral pain radiating from the back along the femoral
or sciatic nerve to the corresponding dermatome of the nerve
